Condensed Consolidated Statements of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended				9 Months Ended
	Sep. 30, 2014		Sep. 30, 2013		Sep. 30, 2014		Sep. 30, 2013
Cash used in operating activities
Net loss and comprehensive loss	$ (4,932)		$ (7,396)		$ (20,032)		$ (20,022)
Adjustments to reconcile net loss to net cash used in operating activities
Depreciation	222		230		680		717
Stock-based compensation and restricted stock based compensation	179		137		1,150		279
Unrealized foreign exchange losses	(11)		69		83		204
Deferred income taxes	(416)		108		(179)		566
Recovery on assets held for sale	0	[1]	(37)	[1]	0	[1]	(212)	[1]
Gain on sale of discontinued operations (Note 10)	0	[2]	0	[2]	0	[2]	(743)	[2]
Gain on sale of long-lived assets	0		(4)		0		(4)
Fair value change in contingent consideration (Note 3)	0		761		0		1,249
Changes in non-cash operating assets and liabilities
Accounts receivable	4		(47)		124		2,158
Prepaid and other assets	228		690		1,077		(264)
Accounts payable	(1,415)		486		(172)		(2,003)
Income taxes receivable / payable	0		204		9		146
Accrued liabilities	84		203		(181)		(1,158)
Accrued restructuring charges	0		(436)		(130)		(1,633)
Cash used in operating activities	(6,057)		(5,032)		(17,571)		(20,720)
Cash provided by investing activities
Net proceeds from sale of long-lived assets	0		30		0		239
Net proceeds from sale of discontinued operations (Note 10)	0		7,502		0		8,252
Purchase of property, plant and equipment	0		(129)		(25)		(129)
Proceeds from contingent consideration (Note 3)	5,544		8,483		36,582		25,035
Cash provided by investing activities	5,544		15,886		36,557		33,397
Cash used in financing activities
Common shares repurchased, including fees	0		0		0		(14,079)
Cash distribution paid to common shareholders (Note 7)	0		0		0		(200,000)
Issuance of common shares	509		0		509		8,317
Cash used in financing activities	509		0		509		(205,762)
Effect of exchange rate changes on cash and cash equivalents	(101)		52		(188)		(213)
Net increase (decrease) in cash and cash equivalents	(105)		10,906		19,307		(193,298)
Cash and cash equivalents, beginning of period	137,933		103,180		118,521		307,384
Cash and cash equivalents, end of period	137,828		114,086		137,828		114,086
Supplementary cash flow information:
Income taxes paid	$ 0		$ 0		$ 1		$ 1

[1] Relates to recoveries on equipment that was previously written down in connection with the sale of our PPDS Technology to Mati.

[2] Relates to the 2013 revenue recognition of funds received from Mati at the end of 2012, which were initially recorded as deferred income, for the 90-day option to acquire assets related to our former PPDS Technology.